LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply
AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.
-
Filed today
-
Companies tracked
NSE & BSE
Listed on
👋Welcome back, there - you're tracking 0 companies
🔔Sign in free to track companies and get alerts the moment they file
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors
Latest Filings -
📋 Filing Types Available on ForgeUp Filings
Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
The company's board will meet on May 15, 2026, to approve its financial results for the quarter and year ended March 31, 2026.
🤖 AI Summary
Kilitch Drugs India Ltd Board Meeting scheduled for Friday, May 15, 2026.
Agenda includes considering and approving audited Financial Results for Q4 FY26 and full FY26.
Both Standalone and Consolidated financial results will be reviewed and approved.
Trading window closed from April 1, 2026, reopening 48 hours post-results disclosure.
Disclosure made pursuant to Regulation 29 of SEBI (LODR) Regulations, 2015.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders at this stage.
👤
Who Is Affected
All shareholders are indirectly affected as the upcoming financial results will provide a performance overview for the period ending March 31, 2026.
🔍
Management Signal
Management is adhering to regulatory requirements by intimating the Board Meeting for financial results approval, indicating commitment to timely disclosures.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List - track these upcoming events
Board Meeting Outcome filing — check for approval of Q4 and full FY26 results.
Full audited financial results disclosure — review revenue, profit, and other metrics.
Any dividend declaration or other board decisions announced on May 15, 2026.
LOW RISKThe filing is a routine board meeting intimation, not detailing any new risks.
💡 Investor Takeaway
Kilitch Drugs India Ltd has scheduled a Board Meeting on May 15, 2026, to consider and approve its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. This intimation is under Regulation 29 of SEBI LODR Regulations.
📅 Company Track Record
No previous filings or specific historical financial data for Kilitch Drugs India Ltd were provided for context.
Based on publicly available historical data. For context only.
All BSE filings we have analysed for Kilitch Drugs India Ltd.
You've read one filing
There are 32,000 more, and one of them is about a company you own
Follow a company and we'll email you the moment it files
again - explained, not just forwarded. Free.
Follow companies and get filings by email
Save any filing to read later
Two full AI analyses every month, free
No card needed. Sign in with Google in two taps.
⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔖
Save filings you care about
Sign in free to save any filing and get notified when the same company files again.
🔖
Save This Filing
Sign in with Google to save this filing and get notified when this company files again. Free, takes 5 seconds.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.